Can you provide the average price target for OSE IMMUNO stock?
8 analysts have analysed OSE.PA and the average price target is 10.81 EUR. This implies a price increase of 153.56% is expected in the next year compared to the current price of 4.264.
OSE IMMUNO (OSE.PA) Forecast, Price Target & Analyst Ratings
EPA:OSE • FR0012127173
Current stock price
4.264 EUR
+0.61 (+16.57%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OSE IMMUNO (OSE.PA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€10.81
Upside
+ 153.56%
From current price of €4.26 to mean target of €10.81, Based on 8 analyst forecasts
Low
€8.28
Median
€10.81
High
€13.65
Price Target Revisions
1 Month
-28.70%
3 Months
-28.70%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for OSE.PA. The average price target is 10.81 EUR. This implies a price increase of 153.56% is expected in the next year compared to the current price of 4.264.
The average price target has been revised downward by 28.7% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.50%
OSE.PA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about OSE.PA.
In the previous month the buy percentage consensus was at a similar level.
OSE.PA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 29, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.302M -30.43% | 2.227M -87.83% | 83.435M 3,646.52% | 21.407M -74.34% | 8.981M -58.05% | 17.271M 92.31% | |
| EBITDA YoY % growth | -14.752M -7.84% | -19.927M -35.08% | 47.045M 336.09% | -4.892M -110.40% | -21.87M -347.07% | -21.564M 1.40% | |
| EBIT YoY % growth | -18.289M -11.96% | -23.347M -27.66% | 43.735M 287.33% | -10.464M -123.93% | -23.067M -120.44% | -18.921M 17.97% | |
| Operating Margin | -99.93% | -1,048.36% | 52.42% | -48.88% | -256.84% | -109.55% | |
| EPS YoY % growth | N/A -75.32% | N/A -9.25% | N/A 298.07% | -0.56 -123.35% | -0.99 -74.91% | -1.01 -2.72% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-34.25%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-42.13%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-32.96%
EBIT Next 5 Year
N/A
OSE IMMUNO / OSE.PA Forecast FAQ
When does OSE IMMUNO (OSE.PA) report earnings?
OSE IMMUNO (OSE.PA) will report earnings on 2026-04-29, after the market close.
Can you provide the analyst count for OSE IMMUNO stock?
The number of analysts covering OSE IMMUNO (OSE.PA) is 8.